SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-100265
Filing Date
2021-08-04
Accepted
2021-08-04 19:50:13
Documents
2
Period of Report
2021-08-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2124202-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2124202-1_3seq1.xml 3 2256
2 EXHIBIT 24 tm2124202d1_ex24.htm EX-24 7761
  Complete submission text file 0001104659-21-100265.txt   11466
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Issuer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address FIVE PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address
Simms Christopher Paul (Reporting) CIK: 0001877012 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36080 | Film No.: 211145777